Background
Methods
Patients and Treatment
Patient, treatment and tumour characteristics
| TARGIT-IORT | EBRT |
---|---|---|
Number of patients (% of total)
| 60 (48%) | 66 (52%) |
Age (mean years +/− SD)
Range
| 63 (+/− 8.2) 50–83 | 62 (+/− 7.4) 50–80 |
Randomised prepathology (before WLE)
Randomised postpathology (after WLE)
| 4 (7%) 56 (93%) | 14 (21%) 52 (79%) |
Baseline assessments prior to any surgery N (% of treatment group)
| 2 (3%) | 12 (18%) |
Baseline BMI (mean score kg/m
2
+/− SD)
Baseline BMI Group
a
(% pf treatment group)
| 29 (+/− 5.5) | 30 (+/− 5.9) |
1 – Underweight (< 18.5)
| 0% | 0% |
2 – Normal (18.5–24.99)
| 30% | 16% |
3 – Overweight (25–29.99)
| 30% | 50% |
4 – Obese (30+)
| 40% | 34% |
Tumour Size (mm mean ± SD)
Tumour Size Group, % of treatment group
| 10 (+/− 4.2) | 11 (+/− 5.0) |
< 11(mm) | 62% | 52% |
11–20 (mm) | 38% | 46% |
> 21(mm)
b
| – | 1.5% |
Tumour Grade, n (% of treatment group)
| ||
1 | 37 (62%) | 38 (57%) |
2 | 23 (38%) | 27 (41%) |
3
b
| 0 | 1 (1.5%) |
Tumour Type, n (% of treatment group)
| ||
IDC Mixed IDC/ILC
b
| 59 (98%) 1 (1.7%) | 64 (97%) 2 (3%) |
Lesions, n (% of treatment group)
| ||
1 | 60 (100%) | 65 (98%) |
2
b
| 0 | 1 (1.5%) |
Extensive DCIS (> 25% of tumour + inside and out of tumour)
b
n (% of treatment group)
| 0 | 4 (6.3%) |
Hormone receptor status, n (% of treatment group)
| ||
ER + ve
| 60 (100%) | 64 (97%) |
PR + ve
| 44 (73%) | 52 (79%) |
ER and PR –ve
b
| 0 | 2 (3%) |
Positive Nodes
b
, n (% of treatment group)
| 0 | 1 (1.5%) (1 node) |
Largest Specimen Length (mean -mm +/− SD)
Range
| 89 (+/− 37.2) 25–205 | 89 (+/− 38.4) 40–267 |
Extent of Axillary Surgery, n (% of treatment group)
| ||
Nil | 3 (5%) | 2 (3%) |
SLNBx | 49 (82%) | 55 (83%) |
Clearance | 8 (13%) | 9 (14%) |
Further Surgery Required, n (% of treatment group)
| ||
SLNBx | 2 (3.3%) | 2 (3%) |
Margins | 2 (3.3%) | 7 (11%) |
Revision of Scar | 2 (3.3%) | 0 |
Radiotherapy Dose Range (Gy)
| 16-33c | 45–50.4 |
Fractions (range)
| 1 | 25 (25–28) |
Boost Given (20Gy in 10 fractions), n (% of treatment group)
| N/A | 11 (17%) |
Supraclavicular Treatment, n (% of treatment group)
| N/A | 1 (1.5%) |
Chemotherapy given
b
(n, % of treatment group)
| 0 | 1 (1.5%) |
Baseline Cosmesis Scores (% Excellent-Good), mean (± SD)
| ||
Patient Harris | 85 (+/− 0.36) | 82 (+/− 0.39) |
Nurse Harris | 93 (+/− 0.25) | 92 (+/− 0.27) |
Doctor Harris† | 87 (+/− 0.35) | 100 (+/− 0.0) |
BCCT.Core | 83 (+/− 0.38) | 90 (0.31) |
Instruments and evaluations
Cosmesis Harris Scale
Analysis and Interpretation
Results
Participants and Compliance
Cosmesis
Review of agreement between cosmesis rating systems
Time-point | Patient vs. Doctor | Patient vs. Nurse | Patient vs. BCCT | Doctor vs. Nurse | Doctor vs. BCCT | BCCT vs. Nurse | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
% agree (n†) | Kappa (p-value) | % agree (n†) | Kappa (p-value) | % agree (n†) | Kappa (p-value) | % agree (n†) | Kappa (p-value) | % agree (n†) | Kappa (p-value) | % agree (n†) | Kappa (p-value) | |
BL | 80.8 (99) | 0.09 (0.59) | 84.1 (107) | 0.19 (0.05) | 74.5 (98) | −0.07 (0.67) | 88.3 (112) | 0.07 (0.40) | 85.1 (101) | 0.15 (0.14) | 81.8 (110) | − 0.01 (1.00) |
Yr1 | 78.5 (93) | 0.31 (0.006)** | 78.8 (104) | 0.37 (0.001)** | 69.1 (97) | 0.22 (0.034*) | 83.3 (102) | 0.46 (< 0.001)** | 68.4 (95) | 0.16 (0.15) | 73.8 (107) | 0.35 (< 0.001)** |
Yr2 | 79.6 (98) | 0.26 (0.018)* | 70.8 (96) | 0.12 (0.35) | 63.3 (79) | −0.06 (0.75) | 73.5 (102) | 0.09 (0.46) | 76.7 (86) | 0.21 (0.048)* | 75.3 (89) | 0.31 (0.005)** |
Yr3 | 73.2 (71) | −0.05 (1.00) | 73.1 (78) | 0.11 (0.45) | 73.2 (41) | −0.01 (1.00) | 73.8 (80) | 0.17 (0.14) | 80.8 (47) | 0.22 (0.16) | 76.0 (50) | 0.35 (0.020)* |
Yr4 | 81.1 (74) | 0.20 (0.099) | 78.9 (71) | 0.01 (1.00) | 66.7 (27) | −0.13 (0.60) | 85.4 (82) | 0.17 (0.17) | 66.7 (27) | −0.13 (0.60) | 72.4 (29) | 0.25 (0.31) |
Yr5 | 78.4 (51) | 0.34 (0.027)* | 75.0 (44) | 0.27 (0.17) | – | – | 80.4 (56) | 0.24 (0.11) | – | – | – | – |
Average Agreement | 78.6 | 76.8 | 69.4 | 80.8 | 75.9 | 75.9 |
Time point | Rater Comparison (% EG) | Kappa | p-value |
---|---|---|---|
1 Year | Patient (76) vs. Doctor^ (82) | 0.312** | 0.006 ## |
1 Year | Patient (76) vs. Nurse (78)^ | 0.366** | 0.001 ## |
1 Year | Patient (76)^ vs. BCCT (68) | 0.222** | 0.034 # |
1 Year | Nurse (78) vs. Doctor (82)^ | 0.461*** | < 0.001 ## |
1 Year | Nurse (78)^ vs. BCCT (68) | 0.345** | < 0.001 ## |
2 Year | Patient (80) vs. Doctor (87)^ | 0.258** | 0.018 # |
2 Year | Doctor (87)^ vs. BCCT (77) | 0.211** | 0.048 # |
2 Year | Nurse (79)^ vs. BCCT (77) | 0.314** | 0.005 ## |
3 Year | Nurse (78) vs. BCCT (81)^ | 0.348** | 0.020 # |
5 Year | Patient (79) vs. Doctor (84)^ | 0.258** | 0.027 # |